CLINICAL_TRIALS
research
· 2025-08-12
Clinical Trial Update: Ketogenic Diet for New-Onset Absence Epilepsy [Phase 3]
Summary
Phase 3 clinical trial evaluating the ketogenic diet for new-onset absence epilepsy is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Johns Hopkins University | Conditions: Absence Epilepsy, Ketogenic Dieting | Phase 3 | Status: RECRUITING